Literature DB >> 16204515

pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.

Domitille Fayol-Messaoudi1, Cédric N Berger, Marie-Hélène Coconnier-Polter, Vanessa Liévin-Le Moal, Alain L Servin.   

Abstract

The mechanism(s) underlying the antibacterial activity of probiotic Lactobacillus strains appears to be multifactorial and includes lowering of the pH and the production of lactic acid and of antibacterial compounds, including bacteriocins and nonbacteriocin, non-lactic acid molecules. Addition of Dulbecco's modified Eagle's minimum essential medium to the incubating medium delays the killing activity of lactic acid. We found that the probiotic strains Lactobacillus johnsonii La1, Lactobacillus rhamnosus GG, Lactobacillus casei Shirota YIT9029, L. casei DN-114 001, and L. rhamnosus GR1 induced a dramatic decrease in the viability of Salmonella enterica serovar Typhimurium SL1344 mainly attributable to non-lactic acid molecule(s) present in the cell-free culture supernatant (CFCS). These molecules were more active against serovar Typhimurium SL1344 in the exponential growth phase than in the stationary growth phase. We also showed that the production of the non-lactic acid substance(s) responsible for the killing activity was dependent on growth temperature and that both unstable and stable substances with killing activity were present in the CFCSs. We found that the complete inhibition of serovar Typhimurium SL1344 growth results from a pH-lowering effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204515      PMCID: PMC1266002          DOI: 10.1128/AEM.71.10.6008-6013.2005

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  26 in total

Review 1.  Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.

Authors:  Alain L Servin
Journal:  FEMS Microbiol Rev       Date:  2004-10       Impact factor: 16.408

2.  Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.

Authors:  Yuan-Kun Lee; Kim-Yoong Puong; Arthur C Ouwehand; Seppo Salminen
Journal:  J Med Microbiol       Date:  2003-10       Impact factor: 2.472

Review 3.  Defensins: antimicrobial peptides of innate immunity.

Authors:  Tomas Ganz
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

4.  Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid.

Authors:  M Ogawa; K Shimizu; K Nomoto; R Tanaka; T Hamabata; S Yamasaki; T Takeda; Y Takeda
Journal:  Int J Food Microbiol       Date:  2001-08-15       Impact factor: 5.277

5.  In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.

Authors:  P K Gopal; J Prasad; J Smart; H S Gill
Journal:  Int J Food Microbiol       Date:  2001-08-05       Impact factor: 5.277

Review 6.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Antimicrobial substance from a human Lactobacillus strain.

Authors:  M Silva; N V Jacobus; C Deneke; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

8.  Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract.

Authors:  G Reid; R L Cook; A W Bruce
Journal:  J Urol       Date:  1987-08       Impact factor: 7.450

9.  In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.

Authors:  D Sgouras; P Maragkoudakis; K Petraki; B Martinez-Gonzalez; E Eriotou; S Michopoulos; G Kalantzopoulos; E Tsakalidou; A Mentis
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

10.  Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments.

Authors:  R C Chan; G Reid; R T Irvin; A W Bruce; J W Costerton
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

View more
  67 in total

Review 1.  Probiotics and chronic kidney disease.

Authors:  Laetitia Koppe; Denise Mafra; Denis Fouque
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

Review 2.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Selection of Potential Probiotic Lactobacillus with Inhibitory Activity Against Salmonella and Fecal Coliform Bacteria.

Authors:  Mattika Abhisingha; Jureeporn Dumnil; Chetsadaporn Pitaksutheepong
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

4.  A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.

Authors:  Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

Review 5.  Probiotics in the next-generation sequencing era.

Authors:  Jotham Suez; Niv Zmora; Eran Elinav
Journal:  Gut Microbes       Date:  2019-04-05

Review 6.  Recent Advances in the Physiology of Spore Formation for Bacillus Probiotic Production.

Authors:  Vladimir Elisashvili; Eva Kachlishvili; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

7.  Community-based interference against integration of Pseudomonas aeruginosa into human salivary microbial biofilm.

Authors:  X He; W Hu; J He; L Guo; R Lux; W Shi
Journal:  Mol Oral Microbiol       Date:  2011-09-13       Impact factor: 3.563

Review 8.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

Review 9.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

10.  Probiotics and necrotizing enterocolitis: finding the missing pieces of the probiotic puzzle.

Authors:  Sherry A Luedtke; Jacob T Yang; Heather E Wild
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.